KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alnylam Pharmaceuticals (ALNY) EPS (Weighted Average and Diluted): 2019-2024

Historic EPS (Weighted Average and Diluted) for Alnylam Pharmaceuticals (ALNY) over the last 6 years, with Dec 2024 value amounting to -$2.18.

  • Alnylam Pharmaceuticals' EPS (Weighted Average and Diluted) rose 311.49% to $1.84 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.24, marking a year-over-year increase of 109.20%. This contributed to the annual value of -$2.18 for FY2024, which is 38.07% up from last year.
  • According to the latest figures from FY2024, Alnylam Pharmaceuticals' EPS (Weighted Average and Diluted) is -$2.18, which was up 38.07% from -$3.52 recorded in FY2023.
  • Over the past 5 years, Alnylam Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at -$2.18 during FY2024, and registered a low of -$9.30 during FY2022.
  • For the 3-year period, Alnylam Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$5, with its median value being -$3.52 (2023).
  • Per our database at Business Quant, Alnylam Pharmaceuticals' EPS (Weighted Average and Diluted) dropped by 29.17% in 2022 and then surged by 62.15% in 2023.
  • Alnylam Pharmaceuticals' EPS (Weighted Average and Diluted) (Yearly) stood at -$7.46 in 2020, then rose by 3.49% to -$7.20 in 2021, then dropped by 29.17% to -$9.30 in 2022, then soared by 62.15% to -$3.52 in 2023, then spiked by 38.07% to -$2.18 in 2024.